320 related articles for article (PubMed ID: 25228314)
41. Structural insights unravel the zymogenic mechanism of the virulence factor gingipain K from
Pomowski A; Usón I; Nowakowska Z; Veillard F; Sztukowska MN; Guevara T; Goulas T; Mizgalska D; Nowak M; Potempa B; Huntington JA; Potempa J; Gomis-Rüth FX
J Biol Chem; 2017 Apr; 292(14):5724-5735. PubMed ID: 28196869
[TBL] [Abstract][Full Text] [Related]
42. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice.
Bittner-Eddy PD; Fischer LA; Costalonga M
Mol Oral Microbiol; 2013 Dec; 28(6):452-66. PubMed ID: 23945018
[TBL] [Abstract][Full Text] [Related]
43. VimA is part of the maturation pathway for the major gingipains of Porphyromonas gingivalis W83.
Vanterpool E; Roy F; Zhan W; Sheets SM; Sangberg L; Fletcher HM
Microbiology (Reading); 2006 Nov; 152(Pt 11):3383-3389. PubMed ID: 17074907
[TBL] [Abstract][Full Text] [Related]
44. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.
Gibson FC; Genco CA
Curr Pharm Des; 2007; 13(36):3665-75. PubMed ID: 18220804
[TBL] [Abstract][Full Text] [Related]
45. Expression of Arg-Gingipain RgpB is required for correct glycosylation and stability of monomeric Arg-gingipain RgpA from Porphyromonas gingivalis W50.
Rangarajan M; Hashim A; Aduse-Opoku J; Paramonov N; Hounsell EF; Curtis MA
Infect Immun; 2005 Aug; 73(8):4864-78. PubMed ID: 16041000
[TBL] [Abstract][Full Text] [Related]
46. Pathogenesis of Important Virulence Factors of
Jia L; Han N; Du J; Guo L; Luo Z; Liu Y
Front Cell Infect Microbiol; 2019; 9():262. PubMed ID: 31380305
[TBL] [Abstract][Full Text] [Related]
47. Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages.
Hajishengallis G; Wang M; Harokopakis E; Triantafilou M; Triantafilou K
Infect Immun; 2006 Oct; 74(10):5658-66. PubMed ID: 16988241
[TBL] [Abstract][Full Text] [Related]
48. Immunologic environment influences macrophage response to Porphyromonas gingivalis.
Papadopoulos G; Shaik-Dasthagirisaheb YB; Huang N; Viglianti GA; Henderson AJ; Kantarci A; Gibson FC
Mol Oral Microbiol; 2017 Jun; 32(3):250-261. PubMed ID: 27346827
[TBL] [Abstract][Full Text] [Related]
49. Porphyromonas gingivalis exacerbates ligature-induced, RANKL-dependent alveolar bone resorption via differential regulation of Toll-like receptor 2 (TLR2) and TLR4.
Lin J; Bi L; Yu X; Kawai T; Taubman MA; Shen B; Han X
Infect Immun; 2014 Oct; 82(10):4127-34. PubMed ID: 25047844
[TBL] [Abstract][Full Text] [Related]
50. Induction of toll-like receptor expression by Porphyromonas gingivalis.
Wara-aswapati N; Chayasadom A; Surarit R; Pitiphat W; Boch JA; Nagasawa T; Ishikawa I; Izumi Y
J Periodontol; 2013 Jul; 84(7):1010-8. PubMed ID: 23003918
[TBL] [Abstract][Full Text] [Related]
51. Triggering NETosis via protease-activated receptor (PAR)-2 signaling as a mechanism of hijacking neutrophils function for pathogen benefits.
Bryzek D; Ciaston I; Dobosz E; Gasiorek A; Makarska A; Sarna M; Eick S; Puklo M; Lech M; Potempa B; Potempa J; Koziel J
PLoS Pathog; 2019 May; 15(5):e1007773. PubMed ID: 31107907
[TBL] [Abstract][Full Text] [Related]
52. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model.
Yonezawa H; Ishihara K; Okuda K
Infect Immun; 2001 May; 69(5):2858-64. PubMed ID: 11292699
[TBL] [Abstract][Full Text] [Related]
53. Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence.
Nakayama K; Kadowaki T; Okamoto K; Yamamoto K
J Biol Chem; 1995 Oct; 270(40):23619-26. PubMed ID: 7559528
[TBL] [Abstract][Full Text] [Related]
54. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.
Genco CA; Potempa J; Mikolajczyk-Pawlinska J; Travis J
Clin Infect Dis; 1999 Mar; 28(3):456-65. PubMed ID: 10194062
[TBL] [Abstract][Full Text] [Related]
55. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis.
Inagaki S; Ishihara K; Yasaki Y; Yamada S; Okuda K
J Periodontol; 2003 Oct; 74(10):1432-9. PubMed ID: 14653388
[TBL] [Abstract][Full Text] [Related]
56. Gingipains from Porphyromonas gingivalis play a significant role in induction and regulation of CXCL8 in THP-1 cells.
Jayaprakash K; Khalaf H; Bengtsson T
BMC Microbiol; 2014 Jul; 14():193. PubMed ID: 25037882
[TBL] [Abstract][Full Text] [Related]
57. Inactive Gingipains from
Glowczyk I; Wong A; Potempa B; Babyak O; Lech M; Lamont RJ; Potempa J; Koziel J
Front Cell Infect Microbiol; 2017; 7():140. PubMed ID: 28497028
[TBL] [Abstract][Full Text] [Related]
58. Requirement of TLR4 and CD14 in dendritic cell activation by Hemagglutinin B from Porphyromonas gingivalis.
Gaddis DE; Michalek SM; Katz J
Mol Immunol; 2009 Aug; 46(13):2493-504. PubMed ID: 19540594
[TBL] [Abstract][Full Text] [Related]
59. Mixed infection of Porphyromonas gingivalis and Bacteroides forsythus in a murine abscess model: involvement of gingipains in a synergistic effect.
Yoneda M; Hirofuji T; Anan H; Matsumoto A; Hamachi T; Nakayama K; Maeda K
J Periodontal Res; 2001 Aug; 36(4):237-43. PubMed ID: 11519697
[TBL] [Abstract][Full Text] [Related]
60. The biphasic virulence activities of gingipains: activation and inactivation of host proteins.
Imamura T; Travis J; Potempa J
Curr Protein Pept Sci; 2003 Dec; 4(6):443-50. PubMed ID: 14683429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
